ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $58,916,000 | -9.5% | 447,859 | -11.3% | 0.60% | -2.1% |
Q1 2021 | $65,105,000 | +16.0% | 505,159 | +50.1% | 0.61% | +24.0% |
Q4 2020 | $56,121,000 | -50.5% | 336,500 | -54.2% | 0.49% | -65.5% |
Q3 2020 | $113,348,000 | -51.0% | 734,500 | -53.0% | 1.42% | -56.2% |
Q2 2020 | $231,166,000 | -37.6% | 1,562,986 | -52.5% | 3.25% | -47.7% |
Q1 2020 | $370,194,000 | -20.4% | 3,287,400 | -1.7% | 6.22% | -6.3% |
Q4 2019 | $465,092,000 | +29.8% | 3,343,100 | -10.1% | 6.64% | -2.3% |
Q3 2019 | $358,231,000 | -19.1% | 3,719,173 | -3.3% | 6.80% | -0.9% |
Q2 2019 | $442,944,000 | -5.2% | 3,846,673 | -3.1% | 6.86% | -5.2% |
Q1 2019 | $467,348,000 | +82.5% | 3,970,673 | -2.9% | 7.24% | +52.8% |
Q4 2018 | $256,074,000 | -13.0% | 4,087,373 | -1.6% | 4.74% | +33.5% |
Q3 2018 | $294,486,000 | +0.3% | 4,155,891 | -5.8% | 3.55% | +1.3% |
Q2 2018 | $293,572,000 | +33.3% | 4,413,291 | +31.1% | 3.50% | +28.2% |
Q1 2018 | $220,222,000 | +63.3% | 3,367,315 | 0.0% | 2.73% | +60.1% |
Q4 2017 | $134,895,000 | +10.5% | 3,367,315 | 0.0% | 1.71% | +46.2% |
Q3 2017 | $122,065,000 | +30.6% | 3,367,315 | 0.0% | 1.17% | +19.1% |
Q2 2017 | $93,477,000 | +22.9% | 3,367,315 | +23.9% | 0.98% | +13.7% |
Q1 2017 | $76,085,000 | +38.3% | 2,717,315 | 0.0% | 0.86% | +23.0% |
Q4 2016 | $54,998,000 | +24.9% | 2,717,315 | +24.0% | 0.70% | +39.6% |
Q3 2016 | $44,039,000 | +51.5% | 2,191,000 | 0.0% | 0.50% | +65.7% |
Q2 2016 | $29,075,000 | +605.4% | 2,191,000 | +885.9% | 0.30% | +604.7% |
Q1 2016 | $4,122,000 | +1.3% | 222,223 | 0.0% | 0.04% | +16.2% |
Q4 2015 | $4,071,000 | +3.5% | 222,223 | 0.0% | 0.04% | -7.5% |
Q3 2015 | $3,933,000 | -84.6% | 222,223 | -84.7% | 0.04% | -78.7% |
Q2 2015 | $25,618,000 | +1.9% | 1,448,991 | 0.0% | 0.19% | -12.6% |
Q1 2015 | $25,140,000 | – | 1,448,991 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |